| Akt | protein kinase B |
| APAF1 | apoptotic protease activating factor 1 |
| APC | adenomatous polyposis coli |
| BAX | BCL2-Associated X Protein |
| Bcl-xL | B-cell lymphoma-extra large |
| BCL2 | B-cell Lymphoma 2 |
| BRAF | proto-oncogene, serine/threonine kinase |
| c-Jun | avian Sarma virus-17 oncogene (Jun comes from Japanese JU-NANA) |
| c-Myc | cellular homologue of avian myelocytomatosis virus |
| CASP3 | caspease-3 |
| CASP8 | caspease-8 |
| CASP9 | caspease-9 |
| CB | candidate biomarker |
| CC3 | Cleaved Caspase-3 |
| CDK-p21 | Cyclin-Dependent Kinase Inhibitor 1 |
| CDK-p72 | Cyclin-Dependent Kinase Inhibitor 1B |
| CDK4 | cyclin-dependent kinase 4 |
| CI | combinational index |
| cIAP1 | cellular inhibitor of apoptosis protein-1 |
| cIAP2 | Baculoviral IAP Repeat-Containing Protein 3 |
| CIN | Chromosomal Instability |
| COX-2 | Cyclooxygenase 2 |
| CRC | colorectal carcinoma |
| CRISPR | clusters of regularly interspaced short palindromic repeats |
| CXCR-4 | C-X-C chemokine receptor type 4 |
| Cyt c | cytochrome complex |
| DCC | deleted in colorectal carcinoma |
| DR | death receptor |
| EGFR | epidermal growth factor receptor |
| EMT | epithelial–mesenchymal transition |
| ERKs | extracellular signal-regulated kinases |
| FAP | Familial Adenomatous Polyposis |
| FCC | Familial Colorectal Cancer |
| FOLFIRI | folinic acid, fluorouracil and irinotecan |
| GADD45 | Growth Arrest and DNA Damage-inducible |
| GDT | Gamma-Delta Tocotrienol |
| HDI | Human Development Index |
| HIF-1α | hypoxia-inducible factor 1-alpha |
| HME | High MYC Expression |
| HMGCR | HMG-CoA reductase |
| HNPCC | Hereditary Non-Polyposis Colorectal Cancer |
| hTERT | human telomerase reverse transcriptase |
| IC50 | half maximum inhibitory concentration |
| ICAM-1 | intercellular adhesion molecule 1 |
| IL-8 | interleukin-8 |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| KO | Knockout |
| KRAS | Kirsten rat sarcoma viral oncogene homolog |
| LEF | lymphoid enhancer-binding factor |
| LME | low MYC Expression |
| LNM | lymph node metastasis |
| MCRC | metastatic colorectal cancer |
| miRNAs | micro-ribonucleic acids |
| MLH1 | MutL homolog 1 |
| MMP-7 | Matrix metalloproteinase-7 or Matrilysin |
| MMP-9 | Matrix Metallopeptidase 9 |
| MSH2 | MutS homolog 2 |
| MSI | Microsatellite Instability |
| MSI-H | Microsatellite Instability High-Frequency |
| MSI-L | Microsatellite Instability Low-Frequency |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| OS | overall survival |
| p-value | calculated probability |
| p38 MAPK | p38 mitogen-activated protein kinases |
| p53 | tumor suppressor protein (MW = 53 kD) |
| PARP-1 | poly [ADP-Ribose] polymerase 1 |
| PFS | progression-free survival |
| PKC | protein kinase C |
| PPI | protein-protein interaction |
| PRISMA | preferred reporting items for systematic reviews and meta-analyses |
| RhoA | transforming protein |
| Ser473 | serine kinase |
| SMAD4 | such as mothers against decapentaplegic homolog 4 |
| T3s | tocotrienols |
| TBE | TCF4/LEF Binding Elements |
| TCF | T-cell factor |
| TCF4 | Transcription Factor 4 |
| TGF-RII | transforming growth factor receptor II |
| Thr308 | threonine kinase |
| TRAIL | tumor Necrosis Factor-Related Apoptosis-Inducing Ligand |
| TRF | tocotrienol-rich fraction |
| TSG | tumor suppressor genes |
| TT | target therapy |
| VEGF | vascular endothelial growth factor |
| VEGFA | vascular endothelial growth factor A |
| Wnt | Wingless-related integration site |
| Wnt-1 | Wingless-related integration site-1 |
| αToc | alpha-tocopherol |
| γT3 | gamma-tocotrienol |
| δT3 | delta-tocotrienol |